# Genetic Testing to Understand and Address Renal Disease Disparities Across the United States Pharmacogenetic Substudy

> **NCT06748040** · NA · COMPLETED · sponsor: **Duke University** · enrollment: 1874 (actual)

## Conditions studied

- Chronic Kidney Disease
- Hypertension

## Interventions

- **OTHER:** Timing of return of results

## Key facts

- **NCT ID:** NCT06748040
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-10
- **Primary completion:** 2024-04-09
- **Final completion:** 2024-05-17
- **Target enrollment:** 1874 (ACTUAL)
- **Last updated:** 2025-06-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06748040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06748040, "Genetic Testing to Understand and Address Renal Disease Disparities Across the United States Pharmacogenetic Substudy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06748040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*